radiolabeled monoclonal antibody

Related by string. * radiolabeling : radiolabeled TM# . radiolabeled ZEVALIN . generation radiolabeled antibody . radiolabeled compounds / monoclonals . Monoclonal : Crucell rabies monoclonal antibody . therapeutic monoclonal antibodies . humanized monoclonal antibody / ANTIBODY . Antibody : Affinity Optimized Antibody . antibody mediated rejection . antibody fragments * *

Related by context. All words. (Click for frequent words.) 70 mertansine 69 PSMA ADC 69 immunoconjugate 68 busulfan 68 monoclonal antibody mAb 68 fluoropyrimidine 67 microtubule inhibitor 67 histone deacetylase inhibitor 67 Anticalins ® 67 MGd 67 peptide antigens 67 potent antiproliferative 67 Pertuzumab 67 gemcitabine carboplatin 67 nucleoside analog 67 liposomal formulation 66 radiolabeled 66 oral antiviral 66 NXL# 66 docetaxel Taxotere ® 66 BMS # 66 immune modulating 66 potent anticancer 66 morpholino 66 histone deacetylase HDAC inhibitor 66 virus AAV 66 cleavable linker 66 amikacin 66 vinca alkaloid 66 metaglidasen 66 immunostimulatory 66 albumin bound paclitaxel 66 TG# [003] 66 hA# 65 OMP #M# 65 Panzem NCD 65 chimeric monoclonal antibody 65 piperacillin tazobactam 65 NEUGENE 65 systemic antifungal 65 ESBA# 65 proteasome inhibitor 65 PDE4 inhibitor 65 immune modulatory 65 alkylating agent 65 vitro cytotoxicity 65 liposomal doxorubicin 65 anti neoplastic 65 Copegus ribavirin 65 preclinically 65 orally bioavailable 65 receptor tyrosine kinase inhibitor 65 novel anticancer 65 oral prodrug 65 gemcitabine cisplatin 65 antidiabetic 65 selective adenosine 65 replicon 65 intravesical instillation 65 Janus Kinase 65 bortezomib Velcade 65 CD# monoclonal antibody 65 muscarinic 65 intravenously administered 65 IMP# 65 antitumoral 65 GW# [003] 65 HepDirect prodrug 65 ENMD # 65 bleomycin 65 Pemetrexed 65 A3 adenosine receptor 65 IgG1 antibody 65 Sym# 65 chemotherapeutic drug 64 Nanobody 64 Kinase Inhibitor 64 vinorelbine tartrate 64 CEQ# 64 Epirubicin 64 Kahalalide F 64 somatostatin receptors 64 MAGE A3 ASCI 64 potent cytotoxic 64 histone deacetylase inhibitors 64 antifibrotic 64 Interferon alpha 64 Darinaparsin 64 Doxorubicin 64 Enzastaurin 64 Factor VIIa 64 tumor vascular disrupting 64 Traficet EN 64 mapatumumab 64 murine monoclonal antibody 64 Mitoxantrone 64 DermaVir 64 tubulin inhibitor 64 pertuzumab 64 Cloretazine 64 beta lactam 64 HDACi 64 dimeglumine 64 PI3K inhibitor 64 VEGF receptor 64 paclitaxel Taxol 64 Alkeran 64 antineoplastic 64 selective kinase inhibitor 64 sorafenib Nexavar 64 CCX# 64 thymalfasin 64 Tumor Necrosis Factor 64 YONDELIS 64 plasmid DNA vaccine 64 Vidaza azacitidine 64 aurora kinase 64 fosbretabulin 64 orally dosed 64 cytoprotective 64 ceftazidime 64 preclinical efficacy 64 azacytidine 64 BAL# [002] 64 novel immunomodulatory 64 immunomodulator 64 Melphalan 64 mTOR inhibitors 64 erythropoietic 64 IMiDs ® 64 tumor specific antigen 64 EZN 64 HGS ETR2 64 thalidomide Thalomid 64 HGS# 64 radionuclide therapy 64 HuMax EGFr 63 non nucleoside 63 immunotoxin 63 AEG# 63 depsipeptide 63 insulin sensitizing 63 humanised antibody 63 antitumor 63 AKT inhibitor 63 vorinostat 63 Thrombin 63 interleukin IL -# 63 Gleevec resistant 63 ibritumomab tiuxetan 63 bortezomib Velcade R 63 ritonavir boosted 63 Aurora Kinase 63 doxorubicin cyclophosphamide 63 Golimumab 63 daunorubicin 63 Blinatumomab 63 macrolide antibiotic 63 microtubule targeting 63 Omacetaxine 63 chemically modified siRNA 63 IAP inhibitors 63 Elotuzumab 63 Anticalins R 63 orally inhaled 63 HuLuc# 63 SRT# [003] 63 intranasal delivery 63 effector function 63 topical antifungal 63 antisense inhibitors 63 uricase 63 FVIIa 63 oral antidiabetic 63 anti CD3 antibody 63 intratumoral injection 63 drug conjugate 63 cytostatic 63 PhG alpha 1 63 Lubiprostone 63 EndoTAG 63 Dacogen decitabine 63 IgG1 63 NOD SCID mice 63 humanized monoclonal 63 syngeneic 63 docetaxel Taxotere R 63 oncolytic 63 Aplidin R 63 adenovector 63 TRAIL receptor 63 Irinotecan 63 IMiDs R 63 galiximab 63 Imprime PGG 63 IgG antibodies 63 MEK inhibitor 63 rxRNA 63 dexamethasone Decadron 63 tipranavir 63 HCV replicon 63 murine models 63 polyclonal 63 PEGPH# 63 hepatoma 63 antiproliferative effects 63 TLR9 agonist 63 immunomodulating 63 targeted antifolate 63 TLK# 63 JAK2 inhibitor 63 ZFP TF 63 albumin naturally occurring 63 Tarvacin 63 PKC# 63 humanized antibody 63 Onconase 63 M2 subunit 63 mycophenolate mofetil 63 antitumor effect 63 florbetaben 63 CORT # 63 ALGRX 63 DAVANAT 63 HGS ETR1 mapatumumab 63 idarubicin 63 prostanoid 63 adenoviral vectors 63 PEGylated interferon 63 annexin 63 CA4P 63 avidin 62 anti secretory 62 Cyclosert 62 benzimidazole 62 camptothecin 62 denileukin diftitox 62 Talabostat 62 erlotinib Tarceva ® 62 cetuximab Erbitux ® 62 NMDA antagonists 62 5 HT4 receptor 62 trans retinoic acid 62 potent antibacterial 62 highly selective endothelin 62 Marqibo TM 62 Zysolin TM 62 Dasatinib 62 hormone LHRH antagonist 62 Immunotherapeutic 62 GRNVAC1 62 tubulin binding 62 anti CD3 62 estramustine 62 Cytotoxic 62 intradermal injection 62 Platinol ® cisplatin 62 cilengitide 62 Triapine R 62 CBLC# 62 Liposomal 62 Aliskiren 62 Antitumor 62 PEG SN# 62 ART# 62 LT NS# 62 topical ophthalmic 62 humanized monoclonal antibodies 62 PARI Pharma GmbH 62 bactericidal activity 62 peptidic 62 interleukin IL 62 HuMax 62 ganetespib 62 Valortim R 62 PEG IFN 62 Aurora kinase 62 favorable pharmacokinetic profile 62 systemic RNAi therapeutic 62 ganciclovir 62 CanAg 62 PI3K/mTOR 62 Ganciclovir 62 acid phosphatase PAP 62 corticosteroid dexamethasone 62 trabectedin 62 radioprotective 62 selective androgen receptor modulator 62 GFT# 62 abacavir Ziagen 62 idraparinux 62 annexin V 62 peptide conjugated 62 PBMCs 62 AEGR 62 histone deacetylase HDAC 62 sulindac 62 PSN# [001] 62 SAR# [004] 62 SAR# [002] 62 pegylated liposomal doxorubicin 62 tumor xenograft models 62 HuMax CD4 62 immunomodulatory 62 Bruton tyrosine kinase Btk 62 AVI NEUGENE 62 HQK 62 huN# DM1 62 alkylating 62 Tyrima 62 Chemokine Receptor 62 BMS# 62 Gemcitabine 62 flavopiridol 62 JAK2 inhibitors 62 monoclonal anti 62 EGFR HER2 62 lexidronam injection 62 tositumomab 62 huC# DM4 62 biologic therapeutics 62 telaprevir VX 62 Omacetaxine mepesuccinate 62 PPARgamma 62 Anticalin ® 62 adenosine A2A 62 siRNA therapeutic 62 monoclonal antibody MAb 62 polymerase inhibitor 62 chemotherapeutic regimen 62 bortezomib Velcade ® 62 CCR2 62 pathophysiological effects 62 gefitinib Iressa 62 oral renin inhibitor 62 radiotherapeutic 62 delta isoform 62 anticancer agents 62 Erlotinib 62 TLR9 agonists 62 DFMO 62 GRN# 62 long acting bronchodilator 62 liposomal delivery 62 vascular disrupting agents 62 intranasal formulation 62 aprepitant 62 Etoposide 62 JAK inhibitors 62 CDDO Im 62 RhuDex ® 62 PROCHYMAL 62 recombinant adeno associated 62 CIMZIA ™ 62 OMNARIS HFA 62 selective inhibition 62 antiresorptive 62 nitric oxide donating 62 Fenretinide 62 tumor antigen 62 monoclonal 62 sd rxRNA 62 beta lactamase inhibitor 62 Pathway Inhibitor 62 Fludara 62 PEGylated 62 TH# [003] 62 systemically administered 62 Belerofon 62 JAK3 62 antiapoptotic 62 teriflunomide 62 AMD# [003] 62 intraperitoneal injection 62 Saizen R 62 bispecific 62 tyrosine kinase inhibitor TKI 62 steroid dexamethasone 62 AMPK activators 62 DNA methyltransferases 62 Peg IFN 61 Locked Nucleic Acid LNA 61 neuroprotective properties 61 protein tyrosine phosphatase 1B 61 neratinib 61 Guanilib 61 nanopharmaceutical 61 potently inhibit 61 Chemophase 61 bevacizumab Avastin ® 61 transduced cells 61 Valortim ® 61 IMiDs ® compound 61 TAKSTA 61 Debio 61 intradermal injections 61 liposomal 61 pan HDAC inhibitor 61 novel prodrug 61 ChronVac C R 61 Panzem R NCD 61 oblimersen 61 NP2 61 proteasome inhibitor bortezomib 61 bevacizumab Avastin 61 TNFa 61 Protein Kinase C 61 administered intranasally 61 nucleoside reverse transcriptase inhibitor 61 XL# XL# 61 MORAb 61 telaprevir dosed 61 CANCIDAS 61 GAP #B# 61 immunomodulatory properties 61 anthracycline chemotherapy 61 pharmacodynamic properties 61 LNP formulations 61 radezolid 61 fibrinolytic 61 BrachySil TM 61 meropenem 61 apoptosis inducing 61 selective antagonist 61 molecularly targeted 61 antiangiogenic agents 61 IFNs 61 Enhanze Technology 61 Ceplene/IL-2 61 Bezielle 61 immunotoxins 61 ibandronate 61 echinocandins 61 VSV G 61 chemokine receptor 61 Camptothecin 61 biotinylated 61 Amplimexon 61 antimitotic 61 Rigel R# 61 ara C 61 rilonacept 61 Granulocyte Colony Stimulating Factor 61 Taxol ® 61 synthetic retinoid 61 caspofungin 61 docetaxel Taxotere 61 CLORETAZINE TM VNP#M 61 Lenocta 61 immune stimulatory 61 IFN α 61 PORxin TM 61 AQ4N 61 selective agonists 61 NK1 61 sorafenib tablets 61 oncolytic virus 61 HSP# inhibitors 61 CRLX# 61 DOXIL 61 dasatinib Sprycel 61 renin inhibitors 61 Resten NG 61 zoledronate 61 somatostatin analogue 61 Interferon alfa 61 etanercept Enbrel 61 Antiangiogenic 61 immunomodulators 61 C5a 61 Dual Opioid 61 NY ESO 61 seliciclib 61 trastuzumab DM1 T DM1 61 single stranded oligonucleotides 61 NEUGENE antisense 61 Aflibercept 61 gemcitabine Gemzar 61 SCH # 61 subcutaneously administered 61 Epidermal Growth Factor Receptor 61 Decitabine 61 Valopicitabine 61 antiangiogenesis 61 monoclonal antibodies mAbs 61 CIMZIA TM 61 ALN HPN 61 nanomolar range 61 Capecitabine 61 reslizumab 61 targeted radiotherapeutic 61 OXi# 61 Lenalidomide 61 lipopeptide 61 gemtuzumab ozogamicin 61 amphotericin B 61 Velcade bortezomib 61 alefacept 61 antimetabolite 61 lumiliximab 61 IAP inhibitor 61 labetuzumab 61 saline placebo 61 vascular disrupting 61 Hycamtin ® 61 boosted protease inhibitor 61 dihydrochloride 61 NS4A 61 novel VDA molecule 61 Nav#.# 61 pharmacodynamic markers 61 Davanat 61 GPIIb IIIa 61 adecatumumab 61 interferon IFN 61 siRNAs targeting 61 intravesical 61 synthetic siRNA 61 Camptosar ® 61 Elvitegravir 61 PNP inhibitor 61 daptomycin 61 anti amnesic 61 Pegylated Interferon 61 Vinorelbine 61 recombinant antibodies 61 Multimeric 61 vWF 61 Immunohistochemical staining 61 HCV protease inhibitors 61 ARG# 61 Litx 61 anti resorptive 61 murine model 61 concurrent chemoradiation 61 isoproterenol 61 tacrolimus ointment 61 anti mitotic 61 Tarvacin TM 61 Epothilones 61 ZOLINZA 61 potent antitumor 61 enzastaurin 61 Hycamtin 61 siRNA knockdown 61 cytotoxics 61 immunotherapeutic agent 61 CD# CEA 61 antiangiogenic activity 61 octreotide acetate 61 orally administered inhibitor 61 HGS ETR1 61 DUROS 61 LB# [003] 61 selective orally bioavailable 61 nucleoside polymerase inhibitor 61 CDK inhibitor 61 Cytochrome P# 61 paclitaxel Taxol ® 61 trastuzumab Herceptin 61 quinolone 61 VNP#M 61 pomalidomide 61 maximally tolerated dose 61 interferon lambda 61 potently inhibited 61 GV# [001] 61 LHRH agonist 61 Aptivus ® 61 adalimumab Humira 61 Aclidinium 61 Orally administered 61 DiLA2 61 Monoclonal Antibody 61 SGLT 61 carboplatin paclitaxel 61 QT QTc 61 antisense compounds 61 YONDELIS R 61 BiTE ® 61 anti EGFR antibody 61 KB# [002] 61 Immunomodulatory 61 Protexia R 61 RAV# 61 Cotara ® 61 nanoviricides 61 Enkephalin 61 GHRH 61 selectively inhibits 61 Topotecan 61 rituximab Rituxan ® 60 taxotere 60 antiproliferative 60 unconjugated 60 SIR Spheres 60 astemizole 60 proprietary polysaccharide 60 HER2 antibody 60 Dalbavancin 60 chemoprotective 60 nucleotide analog 60 prucalopride 60 Cloretazine ® 60 KRN# 60 PRT# 60 Gliadel Wafer 60 Darunavir 60 Anti angiogenic 60 anticancer therapeutics 60 OncoVEX GM CSF 60 Hsp# Inhibitor 60 rFSH 60 PrevOnco 60 zileuton 60 pyrazinamide 60 Piperacillin 60 pyridostigmine 60 refractory prostate cancer 60 microdose 60 mimetic peptide 60 nanomolar 60 Bleomycin 60 proteasome inhibitors 60 Azacitidine 60 sevelamer 60 DNA intercalator 60 iobenguane 60 XmAb# 60 evaluating tivozanib 60 HSP# inhibitor 60 eIF 4E 60 Tarceva TM 60 TLR8 60 Neulasta ® 60 Fluconazole 60 virosome 60 μg dose 60 humanized anti 60 metastatic neuroendocrine tumors 60 pharmacologic stress 60 renin inhibitor 60 temozolomide TMZ 60 poly ADP ribose polymerase 60 Alkaline Phosphatase 60 K ras mutations 60 mCi 60 Bicalutamide 60 tyrosine kinase inhibitor 60 nucleoside analogs 60 liposome formulation 60 protease inhibitor PI 60 plasma kallikrein inhibitor 60 Curaxin 60 ORMD 60 IGF 1R inhibitor 60 melphalan prednisone 60 vidofludimus 60 pramlintide metreleptin combination 60 vivo potency 60 etoposide 60 mGluR2 NAM 60 Anthim 60 pharmacodynamic PD 60 stably transfected 60 targeting moieties 60 sargramostim 60 Alocrest 60 TRAIL R2 60 Alfacell proprietary ribonuclease 60 bexarotene 60 selective agonist 60 administered subcutaneously 60 selectively binds 60 PEGylated anti 60 allogeneic cell 60 picomolar 60 poloxamer 60 ActA 60 subcutaneous immunoglobulin 60 isatoribine 60 antibody fragment 60 farletuzumab 60 NSCLC tumors 60 trastuzumab emtansine T DM1 60 ritonavir boosted protease inhibitor 60 Nanobody ® 60 betamethasone dipropionate 60 anti angiogenic agent 60 hemagglutination inhibition 60 cidofovir 60 FOLFOX chemotherapy 60 Cetrorelix pamoate 60 CG# [003] 60 pegylated recombinant 60 cephalosporin antibiotics 60 Sapacitabine 60 Tesmilifene 60 fluticasone furoate 60 calcitonin gene related 60 HepDirect technology 60 antiproliferative activity 60 TriRima 60 lopinavir 60 Aplidin 60 metformin XR 60 CCR5 mAb 60 pyrimethamine 60 rhIL 7 60 FK# 60 paclitaxel poliglumex 60 Vaprisol 60 topical formulations 60 imetelstat 60 antisense inhibitor 60 SPC# [001] 60 protein kinase inhibitor 60 Vaxfectin TM adjuvant 60 Recombinant Human 60 POTELLIGENT ® 60 T#I [002] 60 PET tracers 60 nucleotide analogue 60 sPLA2 60 DermaVir Patch 60 equimolar 60 investigational molecular imaging 60 targeting CD# 60 G Protein Coupled 60 Ultratrace 60 echinocandin 60 obatoclax 60 transgenic rats 60 pharmacokinetic PK study 60 systemic bioavailability 60 Squalamine 60 standard chemotherapy regimen 60 alvespimycin 60 receptor blocker 60 cyclic peptide 60 TGF beta1 60 Taxotere docetaxel 60 BChE 60 cortisol synthesis 60 resolvin 60 PARP inhibitor 60 antiandrogen 60 TRAIL receptors 60 radiation dosimetry 60 tumorigenicity 60 injected subcutaneously 60 FXIII 60 plasmid encoding 60 Tumor Response 60 Onalta TM 60 Inhalation Solution 60 Nanobodies 60 phosphate binding 60 Receptors GPCRs 60 Maribavir 60 relapsed MM 60 JVRS 60 pharmacologically active isomer 60 Prolongs Survival 60 dacetuzumab 60 photosensitizers 60 cationic lipid 60 rhITF 60 loxapine 60 lenalidomide Revlimid ® 60 tipifarnib 60 potent topoisomerase II 60 prodrug 60 gamma secretase inhibitor 60 lapatinib Tykerb 60 trastuzumab Herceptin R 60 intramuscularly 60 Preclinical studies suggest 60 Captisol Enabled 60 adenosine receptor 60 sunitinib malate 60 IFN g 60 trodusquemine 60 Trofex 60 liposome encapsulated 60 Hizentra 60 Xanafide 60 mitomycin 60 triphosphate 60 PI3K inhibitors 60 Methylnaltrexone 60 Fibroblast Growth Factor Receptor 60 VAPRISOL 60 novel immunotherapeutic 60 KSP inhibitors 60 thyroid hormone receptor 60 Nexavar sorafenib 60 Annexin V 60 pharmacokinetic parameters 60 CD# antibody [001] 60 HER2 ErbB2 60 EP #R 60 CTAP# Capsules 60 Fludara ® 60 HepDirect 60 IGFBP 3 60 talabostat 60 Nucleotide 60 vapreotide acetate 60 antihyperglycemic 60 ALK inhibitor 60 Parathyroid Hormone 60 Trastuzumab 60 renoprotective 60 Fc receptor 60 OvaRex MAb 60 Phase Ib study 60 enzyme inhibitor 60 PI3K/Akt pathway inhibitor 60 ZACTIMA 60 riociguat 60 sodium glucose cotransporter 60 CD# antibodies 60 HCV protease 60 CHOP chemotherapy 60 PSMA antibody 60 mda 7 60 volociximab 60 atazanavir ritonavir 60 adenoviral 60 pegfilgrastim 60 LHRH 60 Phase Ib II 60 SinuNase ™ 60 Vitaxin 60 5 HT2C receptor 60 Sudhir Agrawal D.Phil 60 inotropic 60 clevidipine 60 Aurora kinase inhibitor 60 DB# [003] 60 PD LID 60 JAK inhibitor 60 CD3 monoclonal antibody 60 Dapagliflozin 60 sorafenib Nexavar ® 60 cytokine interleukin 60 co stimulatory molecules 60 nab paclitaxel 60 bicalutamide 60 dosage regimens 60 Smac mimetic 60 G#DT 60 hypoxia selective 60 #F AV 60 posaconazole 60 enzyme cytochrome 60 hapten 60 thapsigargin 60 salmeterol fluticasone 60 enkephalin 60 Janus kinase 60 cisplatin gemcitabine 60 RLY# 60 tanespimycin 60 p# inhibitor 59 colon carcinoma 59 mecamylamine 59 recombinant factor VIIa 59 favorable pharmacokinetic 59 GSK# [001] 59 radiolabeled antibodies 59 Monoclonal antibodies 59 Cloretazine R 59 5 FU leucovorin 59 antineoplastic agents 59 Carfilzomib 59 Gemzar ® 59 Akt inhibitor 59 Anticalins 59 Anti Tumor 59 pegylated interferon alpha 59 Teysuno 59 subcutaneous formulation 59 aflibercept VEGF Trap 59 topical gel formulation 59 potent neuroprotective 59 Humate P 59 Bendamustine 59 mineralocorticoid receptor 59 MTP inhibitor 59 nucleoside reverse transcriptase inhibitors 59 Receptor Antagonists 59 SCIg 59 TPI ASM8 59 Xencor XmAb 59 Gefitinib 59 SERCA2a 59 macrolide antibiotics 59 Anticalin R 59 PKCi 59 thetreatment 59 HDAC Inhibitor 59 bifunctional 59 lenalidomide Revlimid R 59 Doxil ® 59 TELINTRA 59 nicardipine 59 GLPG# 59 xenograft tumor models 59 bendamustine 59 gamma secretase inhibitors 59 nucleoside analogues 59 XmAb 59 REG1 59 CYT# QbG# 59 ATL# [001] 59 investigational protease inhibitor 59 ixabepilone 59 tenofovir Viread 59 beta 1a 59 thymidylate synthase TS 59 small molecule thrombopoietin 59 CB1 antagonists 59 receptor monoclonal antibody 59 granisetron 59 #HT#A 59 stable nucleic acid 59 butyrylcholinesterase 59 long acting muscarinic 59 multitargeted 59 vinca alkaloids 59 cellular cytotoxicity 59 alpha interferon 59 milatuzumab 59 poly ethylene glycol PEG 59 trastuzumab Herceptin ® 59 small molecule tyrosine 59 SGLT2 inhibitors 59 OncoVEX 59 imexon 59 thrombopoietin 59 N acetyl 59 amprenavir 59 intraperitoneally 59 cyclophilin inhibitor 59 MVA BN R 59 BiTE 59 ASONEP 59 Azedra 59 investigational immunotherapy 59 glycosylation profile 59 PET molecular imaging 59 Citroxin ™ 59 darunavir r 59 S#P# 59 microsomal 59 thrombin receptor 59 pharmacokinetic interactions 59 Dynavax HBV vaccine 59 FOLFOX6 59 siRNA duplexes 59 peptidomimetic 59 COX Inhibiting Nitric Oxide 59 Yondelis ® 59 AAV vector 59 Capesaris 59 calcineurin inhibitors 59 retaspimycin hydrochloride 59 MYCAMINE 59 nonnucleoside reverse transcriptase inhibitors 59 administered intraperitoneally 59 sufentanil 59 rhGH 59 Prodarsan ® 59 metformin sulfonylurea 59 vanilloid receptor 59 cisplatin chemotherapy 59 ribavirin RBV 59 TNF Tumor Necrosis Factor 59 monocytic 59 IFN beta 59 humanised monoclonal antibody 59 oral salmon calcitonin 59 LY# [003] 59 prostate carcinoma 59 ADAMTS# 59 5FU 59 monoclonal antibody 59 macrocyclic lactone 59 DCCR 59 TÎ ² 4 59 cytotoxic 59 Kinoid 59 proteinase 59 anticancer agent 59 CLL SLL 59 ARC# [001] 59 novel peptide

Back to home page